Back to Journals » Vascular Health and Risk Management » Volume 11

The MGuard coronary stent: safety, efficacy, and clinical utility

Authors Gracida M, Romaguera R, Jacobi F, Gómez-Hospital J, Cequier A

Received 11 May 2015

Accepted for publication 3 August 2015

Published 18 September 2015 Volume 2015:11 Pages 533—539

DOI https://doi.org/10.2147/VHRM.S68007

Checked for plagiarism Yes

Review by Single-blind

Peer reviewers approved by Prof. Dr. Amudha Kadirvelu

Peer reviewer comments 3

Editor who approved publication: Dr Daniel Duprez


Montserrat Gracida, Rafael Romaguera, Francisco Jacobi, Joan A Gómez-Hospital, Angel Cequier

Heart Diseases Institute, Hospital Universitari de Bellvitge – IDIBELL, University of Barcelona, Barcelona, Spain

Abstract: Atheromatous and thrombotic embolization during percutaneous coronary revascularization is a feared complication that may cause impaired myocardial reperfusion even with a patent epicardial vessel. The MGuard stent is a cobalt chromium bare metal stent with a porous net attached to its outer surface that has been designed to prevent thrombus fragmentation and distal embolization during stent implantation. This review summarizes the available evidence supporting the use of the MGuard stent in different scenarios such as lesions with high thrombus burden, saphenous vein graft interventions, coronary perforations, or carotid lesions.

Keywords: Coronary artery disease, myocardial infarction, coronary stent, complication, thrombus, no-reflow phenomenon

Creative Commons License This work is published and licensed by Dove Medical Press Limited. The full terms of this license are available at https://www.dovepress.com/terms.php and incorporate the Creative Commons Attribution - Non Commercial (unported, v3.0) License. By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. For permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms.

Download Article [PDF]  View Full Text [HTML][Machine readable]